Phibro Animal Health Corporation (PAHC) Q2 FY26 Earnings Call

Management raised FY2026 guidance after 21% sales growth and 41% adjusted EBITDA growth [26].

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Call date2026-02-08
Length29 minutes
EPS$0.87
EPS consensus$0.69
Revenue$373.9M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q4 FY25

All PAHC earnings ยท Back to PAHC overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.